Drug
Brenipatide clinical trials
Also written LY3537031.
Keep track of what changes. Save the brenipatide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
18 studies that test it; most in 2025 (8)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 8 |
| 2026 | 8 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 18 · Other 0
Studies
Open first, then newest update. How each study uses brenipatide is read from its arms, and is right about nine times in ten.
Testing it · 18
- A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaRecruitingPhase 2Eli Lilly and CompanyNCT07219173Written as Brenipatide
- A Study of Brenipatide in Participants With Alcohol Use DisorderRecruitingPhase 3Eli Lilly and CompanyNCT07219953Written as LY3537031
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)RecruitingPhase 2Eli Lilly and CompanyNCT07545759Written as LY3537031
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)RecruitingPhase 2Eli Lilly and CompanyNCT07545772Written as LY3537031
- A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)RecruitingPhase 2Eli Lilly and CompanyNCT07759245Written as Brenipatide
- A Study of Brenipatide in Adult Participants With SchizophreniaRecruitingPhase 2Eli Lilly and CompanyNCT07410507Written as Brenipatide
- A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use DisorderRecruitingPhase 3Eli Lilly and CompanyNCT07219966Written as LY3537031
- A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)RecruitingPhase 2Eli Lilly and CompanyNCT07286175Written as Brenipatide
- A Study of Brenipatide in Participants With Opioid Use DisorderRecruitingPhase 2Eli Lilly and CompanyNCT07420283Written as Brenipatide
- A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive DisorderRecruitingPhase 3Eli Lilly and CompanyNCT07775300Written as Brenipatide
- A Study of Brenipatide in Adult Participants With Major Depressive DisorderRecruitingPhase 3Eli Lilly and CompanyNCT07412756Written as Brenipatide
- A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver ImpairmentRecruitingPhase 1Eli Lilly and CompanyNCT07165002Written as LY3537031
- A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid RelapseRecruitingPhase 2Eli Lilly and CompanyNCT07223840Written as Brenipatide
- A Study of LY3537031 in Overweight, Obese, and Healthy ParticipantsActive, not recruitingPhase 1Eli Lilly and CompanyNCT06606106Written as LY3537031
- A Study of How the Body Absorbs LY3537031CompletedPhase 1Eli Lilly and CompanyNCT07202871Written as LY3537031
- A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or ObesityActive, not recruitingPhase 1Eli Lilly and CompanyNCT07476118Written as Brenipatide
- A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal ImpairmentCompletedPhase 1Eli Lilly and CompanyNCT07165015Written as LY3537031
- A Study of LY3537031 in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT04648865Written as LY3537031
Codes
What other systems call brenipatide · ClinicalTrials.gg INT016163
- UNII (FDA) C3939LZT6JBRENIPATIDEOne source FDA
- NCI Thesaurus C223275BrenipatideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | C3939LZT6J | BRENIPATIDE | One source FDA |
| NCI Thesaurus | C223275 | Brenipatide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.